Related Experiment Video

Updated: Aug 18, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
07:08

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein

Published on: January 16, 2020

Interaction between Brk kinase and insulin receptor substrate-4

Haoqun Qiu1, Francesca Zappacosta, Wenjuan Su

  • 1Department of Physiology and Biophysics, School of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794-8661, USA.

Oncogene
|May 5, 2005
PubMed

Insights

Breast tumor kinase (Brk) interacts with insulin receptor substrate 4 (IRS-4), a novel binding partner. This interaction, involving Brk

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Breast tumor kinase (Brk) is a nonreceptor tyrosine kinase overexpressed in human breast tumors.
  • Downstream substrates and effectors of Brk are largely unknown, hindering understanding of its role in breast cancer.

Purpose of the Study:

  • To identify novel binding partners of Breast tumor kinase (Brk).
  • To investigate the interaction between Brk and insulin receptor substrate 4 (IRS-4).

Main Methods:

  • Immunoprecipitation and mass spectrometry to identify Brk binding partners.
  • Confirmation of Brk-IRS-4 association in HEK 293 cells under various conditions.
  • Analysis of Brk tyrosine phosphorylation in MCF-7 and A431 cells.

Main Results:

  • Insulin receptor substrate 4 (IRS-4) was identified as a novel Brk binding partner.
  • Brk associates with IRS-4 in both resting and IGF-1-stimulated cells, mediated by Brk's SH3 and SH2 domains.
  • IRS-4 enhances IGF-1-induced tyrosine phosphorylation of Brk in breast cancer cells.

Conclusions:

  • Breast tumor kinase (Brk) interacts with insulin receptor substrate 4 (IRS-4).
  • The interaction between Brk and IRS-4 may play a role in breast cancer progression.
  • Further research is warranted to elucidate the functional implications of the Brk-IRS-4 complex.

More Related Videos

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay08:34

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...